Evofem Biosciences, Inc. (EVFM)
OTCMKTS · Delayed Price · Currency is USD
0.0090
-0.0002 (-2.17%)
Apr 2, 2025, 4:00 PM EST

Evofem Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
111861196
Upgrade
Market Cap Growth
-12.38%-12.38%-83.76%-87.13%-68.73%-32.18%
Upgrade
Enterprise Value
525044114149165
Upgrade
Last Close Price
0.010.010.068.00704.064518.75
Upgrade
PE Ratio
--0.03---
Upgrade
PS Ratio
0.040.060.070.477.43439.20
Upgrade
PB Ratio
-0.02-0.02-0.02-0.11-0.61145.42
Upgrade
P/TBV Ratio
-----145.42
Upgrade
EV/Sales Ratio
2.672.612.436.7618.08370.72
Upgrade
Debt / Equity Ratio
-0.69-0.69-0.70-0.99-1.1663.80
Upgrade
Asset Turnover
1.131.131.020.500.110.01
Upgrade
Inventory Turnover
2.342.341.840.680.55-
Upgrade
Quick Ratio
0.120.120.080.040.100.65
Upgrade
Current Ratio
0.170.170.130.140.221.26
Upgrade
Return on Equity (ROE)
------1675.90%
Upgrade
Return on Assets (ROA)
-27.94%-27.94%-62.46%-155.38%-136.74%-93.68%
Upgrade
Return on Capital (ROIC)
----681.28%-201.66%-125.61%
Upgrade
Earnings Yield
-841.35%-789.50%4136.67%-972.56%-334.95%-72.65%
Upgrade
FCF Yield
-365.91%-347.43%-700.55%-897.15%-244.21%-54.67%
Upgrade
Buyback Yield / Dilution
92.36%92.36%-211082.03%-567.40%-94.93%-66.94%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.